SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 362 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $247,000 | +21.1% | 1,437 | -0.1% | 0.02% | 0.0% |
| Q3 2020 | $204,000 | -13.9% | 1,439 | -2.7% | 0.02% | -14.3% |
| Q2 2020 | $237,000 | +17.9% | 1,479 | -4.5% | 0.02% | +61.5% |
| Q4 2019 | $201,000 | -15.2% | 1,549 | -0.4% | 0.01% | -27.8% |
| Q2 2019 | $237,000 | -73.2% | 1,556 | -91.7% | 0.02% | -77.5% |
| Q3 2013 | $884,000 | +47.8% | 18,741 | +19.0% | 0.08% | +35.6% |
| Q2 2013 | $598,000 | – | 15,747 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |